New Zealand: a promising destination for trials in a post-Covid-19 world?

newsCOVID-19
Written By Guest User

COVID-19 has delayed or shut down many clinical trials around the world where it is no longer safe or practical to continue. This has led to much interest in our beautiful home of Aotearoa as a base for key healthcare research. Read more in this artice by Pharmaceutical Technology:

https://www.pharmaceutical-technology.com/features/new-zealand-trials-post-covid-19/

Guest User
Previous

The death toll from COVID-19 may have been underestimated by at least 35%
Next

Oxygen: How Much Do We Really Need?